肝海绵状血管瘤的肝动脉栓塞治疗及并发症分析

Hepatic artery embolization for cavernous hemangioma of liver with analysis of complincaltions

目的 评价和分析肝动脉栓塞治疗肝海绵状血管瘤的疗效及并发症。方法 治疗肝血管瘤 34例 ,瘤体大小为 2 .5cm× 2 .0cm～ 9.0cm× 12 .0cm ,采用Seldinger技术股动脉插管 ,导管超选择插至肝血管瘤供血动脉后 ,灌注平阳霉素碘化油乳剂。所有病例术后随访 6～ 18个月。结果 肝动脉栓塞后肝血管瘤瘤体内碘油沉积良好 ,32例 (94 .1% )血管瘤瘤体有不同程度缩小 ,1例发生肝坏死及肝内胆管毁损性并发症 ,5例发生胆囊炎 ,并发症发生率为 17.6 % (6 34)。结论 肝动脉灌注平阳霉素碘化油乳剂治疗肝海绵状血管瘤并不是一种”无损伤”的治疗方法 ,必须严格掌握其适应证。

Objective To investigate and evaluate the clinical value and therapeutic effect of hepatic artery embolization for cavernous hemangioma of liver. Methods 34 cases of cavernous hemangioma of liver were treated with pingyangmycin lipiodol emulsion(PLE) by transcatheter arterial embolization with Seldinger techniqne.The sizes of tumor varied from 2.5 cm×2.0 cm to 9.0 cm×12.0 cm.All cases were followed up 6 to 18 months after the procedure. Results The iodized oil deposited well and all of the tumors shranked with different degrees after the embolization therapy. Complications happened to have liver necrosis in one, cholecystitis in five with rate of complication of 17.6%(6/34). Conclusions The transcartheter arterial injection of PLE to treat cavernous hemangioma of liver is a safe and effective method, but its indiscriminate use should be prohibited.